Anteris Technologies Global (AVR) & Its Peers Critical Comparison

Anteris Technologies Global (NASDAQ:AVR) is one of 511 public companies in the “Healthcare Equipment & Supplies” industry, but how does it weigh in compared to its peers? We will compare Anteris Technologies Global to similar companies based on the strength of its analyst recommendations, dividends, institutional ownership, profitability, valuation, risk and earnings.

Analyst Ratings

This is a summary of current ratings for Anteris Technologies Global and its peers, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Anteris Technologies Global	1	1	3	0	2.40
Anteris Technologies Global Competitors	4257	10483	18210	824	2.46

Anteris Technologies Global presently has a consensus price target of $14.00, indicating a potential upside of 121.87%. As a group, “Healthcare Equipment & Supplies” companies have a potential upside of 25.74%. Given Anteris Technologies Global’s higher probable upside, equities research analysts clearly believe Anteris Technologies Global is more favorable than its peers.

Profitability

This table compares Anteris Technologies Global and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Anteris Technologies Global	-4,619.27%	-77.69%	-67.99%
Anteris Technologies Global Competitors	-278.23%	-150.06%	-21.87%

Earnings and Valuation

This table compares Anteris Technologies Global and its peers revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Anteris Technologies Global	$1.91 million	-$94.14 million	-3.24
Anteris Technologies Global Competitors	$1.89 billion	$138.79 million	10.75

Anteris Technologies Global’s peers have higher revenue and earnings than Anteris Technologies Global. Anteris Technologies Global is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Institutional and Insider Ownership

40.6% of shares of all “Healthcare Equipment & Supplies” companies are held by institutional investors. 4.5% of Anteris Technologies Global shares are held by company insiders. Comparatively, 14.9% of shares of all “Healthcare Equipment & Supplies” companies are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Volatility & Risk

Anteris Technologies Global has a beta of 2.02, indicating that its share price is 102% more volatile than the S&P 500. Comparatively, Anteris Technologies Global’s peers have a beta of 2.57, indicating that their average share price is 157% more volatile than the S&P 500.

Summary

Anteris Technologies Global peers beat Anteris Technologies Global on 10 of the 13 factors compared.

Anteris Technologies Global Company Profile

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.